CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 114 filers reported holding CHEMOCENTRYX INC in Q2 2018. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,653,448,000 | +110.8% | 70,721 | +1.1% | 0.00% | +100.0% |
Q2 2022 | $1,733,434,000 | +0.2% | 69,953 | +1.4% | 0.00% | 0.0% |
Q1 2022 | $1,729,378,000 | -39.5% | 68,982 | -12.2% | 0.00% | 0.0% |
Q4 2021 | $2,860,298,000 | +139.5% | 78,558 | +12.5% | 0.00% | – |
Q3 2021 | $1,194,127,000 | -4.2% | 69,832 | -25.0% | 0.00% | -100.0% |
Q2 2021 | $1,246,141,000 | -59.0% | 93,065 | +56.8% | 0.00% | 0.0% |
Q1 2021 | $3,040,581,000 | -15.7% | 59,340 | +1.9% | 0.00% | -50.0% |
Q4 2020 | $3,606,593,000 | +37.0% | 58,246 | +21.3% | 0.00% | +100.0% |
Q3 2020 | $2,631,607,000 | -5.3% | 48,022 | -0.6% | 0.00% | -50.0% |
Q2 2020 | $2,778,895,000 | +76.7% | 48,295 | +23.4% | 0.00% | +100.0% |
Q1 2020 | $1,572,484,000 | -15.5% | 39,136 | -16.9% | 0.00% | 0.0% |
Q4 2019 | $1,861,738,000 | +667.3% | 47,073 | +31.5% | 0.00% | – |
Q3 2019 | $242,643,000 | +20.5% | 35,788 | +65.4% | 0.00% | – |
Q2 2019 | $201,280,000 | -4.6% | 21,643 | +29.6% | 0.00% | – |
Q3 2018 | $211,088,000 | -4.0% | 16,700 | 0.0% | 0.00% | – |
Q2 2018 | $219,939,000 | – | 16,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 7,796,516 | $45,142,000 | 7.90% |
GREAT POINT PARTNERS LLC | 1,000,000 | $5,790,000 | 4.09% |
Belmont Global Advisors, Inc. | 175,000 | $1,013,000 | 0.82% |
Broadfin Capital, LLC | 1,033,668 | $5,985,000 | 0.79% |
WASATCH ADVISORS LP | 2,650,551 | $15,347,000 | 0.15% |
BALYASNY ASSET MANAGEMENT L.P. | 1,158,613 | $6,708,000 | 0.09% |
Artal Group S.A. | 275,000 | $1,592,000 | 0.06% |
STONERIDGE INVESTMENT PARTNERS LLC | 41,355 | $239,000 | 0.05% |
A.R.T. Advisors, LLC | 33,501 | $193,000 | 0.01% |
BANQUE PICTET & CIE SA | 50,932 | $295,000 | 0.01% |